Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus
Tiphaine Goulenok, Céline Mendes, L. Dayan, Valentine Marie Ferré, Margot Bucau, Fatima Farhi, T. Papo, Karim Sacré
Abstract
Women with systemic lupus erythematosus (SLE), especially when exposed to immunosuppressive drugs, are at higher risk of human papillomavirus (HPV)-related cervical cancer.<sup>1</sup> A recent study has shown that cervical cancer screening (CCS) coverage is worryingly low in this population.<sup>2</sup>
Topics & Concepts
MedicineCervical cancerHuman papillomavirusSystemic diseaseLupus erythematosusCancerConnective tissue diseasePopulationDermatologyInternal medicineImmunologyOncologyImmunopathologyAutoimmune diseaseDiseaseAntibodyEnvironmental healthCervical Cancer and HPV ResearchSystemic Lupus Erythematosus ResearchLymphoma Diagnosis and Treatment